[Prevention of infectious complications in patients with myelosuppression by means of isolation and oral administration of non-absorptive antibiotics (evaluation of clinical effectiveness)].
D000208:Acute Disease; D000284:Administration, Oral; D000380:Agranulocytosis / Q000150:complications* / Q000276:immunology; D005069:Evaluation Studies as Topic; D006801:Humans; D017053:Infection Control; D007612:Kanamycin / Q000008:administration & dosage*; D007938:Leukemia / Q000276:immunology; D009503:Neutropenia / Q000150:complications*; D009761:Nystatin / Q000008:administration & dosage*; D010357:Patient Isolators; D011113:Polymyxins / Q000008:administration & dosage*; D011832:Radiation Injuries / Q000276:immunology; D012310:Ristocetin / Q000008:administration & dosage*
D011113:Polymyxins; D009761:Nystatin; D012310:Ristocetin; D007612:Kanamycin
Profilaktika infektsionnykh oslozhnenii u bol'nykh s mielodepressiami pri pomoshchi izoliatsii i priema vnutr' nevsasyvaemykh antibiotikov (k voprosu ob otsenke klinicheskoĭ effektivnosti.